CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that it has submitted two separate Investigational New Drug (IND ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback